Dyadic International (DYAI) 1.6200 $DYAI
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
Dyadic International Reports First Quarter 2016 Financial Results
GlobeNewswire - Thu May 12, 3:05PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX
YAI), a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help speed up the development and production of biologic vaccines and drugs at flexible commercial scales, today announced financial results for the quarter ending March 31, 2016.
Global Industrial Enzymes Market Report 2015-2020 - Analysis, Technologies & Forecasts - Key Vendors: BASF, DuPont, Dyadic International - Research and Markets
BusinessWire - Mon Apr 18, 8:30AM CDT
Research and Markets has announced the addition of the "Industrial Enzymes Market By Type (Lipase, Carbohydrase, Protease and Others), By Application (Food & Beverages, Bio Fuel, Cleaning Agents, Animal Feed, Textiles, Pulp & Paper and Others) and By Geography- Forecast (2015-2020)" report to their offering.
Dyadic International Announces It Has Reached a Settlement With One of the Two Remaining Defendant Law Firms in Its Professional Liability Litigation
GlobeNewswire - Wed Apr 06, 3:05PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQXYAI), today announced it has reached a confidential settlement with one of the two remaining defendant law firms in its ongoing professional liability litigation.
Dyadic International Reports 2015 Annual Financial Results
GlobeNewswire - Tue Mar 29, 3:04PM CDT
- Dyadic Closes $75 Million DuPont Transaction on December 31, 2015 -
DD: 61.85 (-1.11)
Dyadic International to Announce Year-End 2015 Financial Results and Host Conference Call on Tuesday, March 29, 2016
GlobeNewswire - Tue Mar 15, 3:30PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQXYAI), a global biotechnology company announced today that it will report its financial results for the year ending December 31, 2015 after the market close on Tuesday, March 29, 2016 and that it will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results.
Dyadic International, Inc. Announces a January 6, 2017 Trial Date for Litigation Against Former Professional Services Providers
GlobeNewswire - Thu Mar 03, 3:30PM CST
Dyadic International, Inc. (OTCQXYAI) ("Dyadic" announced today that in its lawsuit against Defendants Greenberg Traurig, LLP, Greenberg Traurig, P.A. (collectively, "Greenberg Traurig" and the Estate of Robert I. Schwimmer, who previously represented the Company while an attorney at Greenberg Traurig, and also against Defendant Bilzin Sumberg Baena Price & Axelrod LLP ("Bilzin Sumberg", the Court issued an Order dated March 2, 2016 scheduling the lawsuit for a six-week jury trial commencing Friday, January 6, 2017.
Looking Into the Price Movements - Consensus Reports on Hemp, RCS Capital, Agora Holdings and Dyadic International
ACCESSWIRE - Mon Feb 01, 8:15AM CST
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Hemp Inc. (OTC: HEMP), RCS Capital Corp. (OTC: RCAP), Agora Holdings Inc. (OTC: AGHI) and Dyadic International Inc. (OTC: DYAI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Traders Look to Upside - Analyst Research on SandRidge Energy, Elite Pharmaceuticals, Dyadic International and Accretive Health
ACCESSWIRE - Thu Jan 21, 8:34AM CST
NEW YORK, NY / ACCESSWIRE / January 21, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: SandRidge Energy Inc. (OTC: SDOC), Elite Pharmaceuticals Inc. (OTC: ELTP), Dyadic International Inc. (OTC: DYAI) and Accretive Health Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
SD: 0.15 (-0.02)
Dyadic Announces Robert Burke Resignation
GlobeNewswire - Tue Jan 19, 3:30PM CST
Dyadic International, Inc. (OTCQXYAI) ("Dyadic" announced today that Robert D. Burke, MD has resigned from the Board of Directors of Dyadic (the 'Board' and all related board committees to which he served which included the compensation, and nominating committees of the board effective January 18, 2016.
DD: 61.85 (-1.11)
Identifying Opportunity, Placing Risk -- Free Research Reports on Terra Tech, Unicharm, First Pacific and Dyadic International
ACCESSWIRE - Thu Jan 14, 7:35AM CST
NEW YORK, NY / ACCESSWIRE / January 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Terra Tech Corp. (OTC: TRTC), Unicharm Corp. (OTC: UNICY), First Pacific Co. Ltd. (OTC: FPAFY) and Dyadic International Inc. (OTC: DYAI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Dyadic International, Inc. Announces the Purchase of 2.1 Million Shares of Its Common Stock From Abengoa Bioenergy New Technologies, LLC, in a Negotiated Transaction
GlobeNewswire - Tue Jan 12, 3:30PM CST
Dyadic International, Inc. (OTCQXYAI) ("Dyadic" announced that it repurchased and retired an aggregate of 2,136,752 shares of its common stock at $1.35 per share for an aggregate purchase price of $2,884,615 pursuant to a Securities Purchase Agreement entered into with Abengoa Bioenergy New Technologies, LLC ("ABNT" on January 12, 2016. The $1.35 per share price is equal to the average conversion price that Dyadic convertible debt holders received upon conversion of debt at December 31, 2015.
DuPont Purchases Dyadic's Industrial Technology Business
Zacks Equity Research - Zacks Investment Research - Mon Jan 04, 8:40AM CST
DuPont (DD) declared that Dyadic International completed the sale of all of the assets of its Industrial Technology business to DuPont's Industrial Biosciences business.
CE: 64.72 (unch), DD: 61.85 (-1.11), DOW: 48.12 (-0.64)
Dyadic International, Inc. Announces Closing of Sale of Industrial Technology Business to Dupont Industrial Biosciences
GlobeNewswire - Thu Dec 31, 9:16AM CST
Dyadic International, Inc. (OTCQXYAI) ("Dyadic" announced the closing of the previously announced sale of substantially all of the assets of its Industrial Technology business to DuPont's (NYSED) Industrial Biosciences business for $75 million in cash (the "Transaction". As previously announced, following the closing, Dyadic intends to focus exclusively on its biopharmaceutical business.
DD: 61.85 (-1.11)
Dyadic International, Inc. Shareholders Approve Sale of Industrial Technology Business to DuPont Industrial Biosciences
GlobeNewswire - Fri Dec 11, 12:25PM CST
Dyadic International, Inc. (OTCQXYAI) ("Dyadic" announced that at the special meeting of Dyadic shareholders held today, Dyadic's shareholders voted to approve the sale of substantially all of the enzyme and technology assets, including the C1 platform of Dyadic, Dyadic International (USA), Inc. ("Dyadic USA" and Dyadic Nederland B.V. to Danisco US Inc., a wholly-owned subsidiary of E. I. du Pont de Nemours and Company, ("Danisco" and its affiliate (the "Transaction" pursuant to the asset purchase and sale agreement, dated as of November 9, 2015, by and among Danisco, Dyadic USA and Dyadic (the "Transaction Agreement".
Dyadic International Reports Third Quarter 2015 Financial Results
GlobeNewswire - Thu Nov 12, 3:30PM CST
Dyadic to Host Investor Conference Call Thursday, November 12, 2015 at 5:00PM EST
DuPont Industrial Biosciences to Acquire Biotechnology Assets from Dyadic
PRWeb - Tue Nov 10, 7:09AM CST
DuPont Industrial Biosciences (DuPont) has signed an agreement to purchase enzyme and technology assets from Dyadic International, Inc., including Dyadic's C1 platform, a fungal expression technology for producing enzymes. The transaction will further extend the world-leading biotechnology capabilities of DuPont's Industrial Biosciences business.
DD: 61.85 (-1.11)
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
Dyadic International Reports First Quarter 2016 Financial Results
GlobeNewswire - Thu May 12, 3:05PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQXYAI), a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help speed up the development and production of biologic vaccines and drugs at flexible commercial scales, today announced financial results for the quarter ending March 31, 2016. Global Industrial Enzymes Market Report 2015-2020 - Analysis, Technologies & Forecasts - Key Vendors: BASF, DuPont, Dyadic International - Research and Markets
BusinessWire - Mon Apr 18, 8:30AM CDT
Research and Markets has announced the addition of the "Industrial Enzymes Market By Type (Lipase, Carbohydrase, Protease and Others), By Application (Food & Beverages, Bio Fuel, Cleaning Agents, Animal Feed, Textiles, Pulp & Paper and Others) and By Geography- Forecast (2015-2020)" report to their offering.
Dyadic International Announces It Has Reached a Settlement With One of the Two Remaining Defendant Law Firms in Its Professional Liability Litigation
GlobeNewswire - Wed Apr 06, 3:05PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQXYAI), today announced it has reached a confidential settlement with one of the two remaining defendant law firms in its ongoing professional liability litigation. Dyadic International Reports 2015 Annual Financial Results
GlobeNewswire - Tue Mar 29, 3:04PM CDT
- Dyadic Closes $75 Million DuPont Transaction on December 31, 2015 -
DD: 61.85 (-1.11)
Dyadic International to Announce Year-End 2015 Financial Results and Host Conference Call on Tuesday, March 29, 2016
GlobeNewswire - Tue Mar 15, 3:30PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQXYAI), a global biotechnology company announced today that it will report its financial results for the year ending December 31, 2015 after the market close on Tuesday, March 29, 2016 and that it will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results. Dyadic International, Inc. Announces a January 6, 2017 Trial Date for Litigation Against Former Professional Services Providers
GlobeNewswire - Thu Mar 03, 3:30PM CST
Dyadic International, Inc. (OTCQX
YAI) ("Dyadic" announced today that in its lawsuit against Defendants Greenberg Traurig, LLP, Greenberg Traurig, P.A. (collectively, "Greenberg Traurig" and the Estate of Robert I. Schwimmer, who previously represented the Company while an attorney at Greenberg Traurig, and also against Defendant Bilzin Sumberg Baena Price & Axelrod LLP ("Bilzin Sumberg", the Court issued an Order dated March 2, 2016 scheduling the lawsuit for a six-week jury trial commencing Friday, January 6, 2017. Looking Into the Price Movements - Consensus Reports on Hemp, RCS Capital, Agora Holdings and Dyadic International
ACCESSWIRE - Mon Feb 01, 8:15AM CST
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Hemp Inc. (OTC: HEMP), RCS Capital Corp. (OTC: RCAP), Agora Holdings Inc. (OTC: AGHI) and Dyadic International Inc. (OTC: DYAI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Traders Look to Upside - Analyst Research on SandRidge Energy, Elite Pharmaceuticals, Dyadic International and Accretive Health
ACCESSWIRE - Thu Jan 21, 8:34AM CST
NEW YORK, NY / ACCESSWIRE / January 21, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: SandRidge Energy Inc. (OTC: SDOC), Elite Pharmaceuticals Inc. (OTC: ELTP), Dyadic International Inc. (OTC: DYAI) and Accretive Health Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
SD: 0.15 (-0.02)
Dyadic Announces Robert Burke Resignation
GlobeNewswire - Tue Jan 19, 3:30PM CST
Dyadic International, Inc. (OTCQX
YAI) ("Dyadic" announced today that Robert D. Burke, MD has resigned from the Board of Directors of Dyadic (the 'Board' and all related board committees to which he served which included the compensation, and nominating committees of the board effective January 18, 2016. DD: 61.85 (-1.11)
Identifying Opportunity, Placing Risk -- Free Research Reports on Terra Tech, Unicharm, First Pacific and Dyadic International
ACCESSWIRE - Thu Jan 14, 7:35AM CST
NEW YORK, NY / ACCESSWIRE / January 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Terra Tech Corp. (OTC: TRTC), Unicharm Corp. (OTC: UNICY), First Pacific Co. Ltd. (OTC: FPAFY) and Dyadic International Inc. (OTC: DYAI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Dyadic International, Inc. Announces the Purchase of 2.1 Million Shares of Its Common Stock From Abengoa Bioenergy New Technologies, LLC, in a Negotiated Transaction
GlobeNewswire - Tue Jan 12, 3:30PM CST
Dyadic International, Inc. (OTCQX
YAI) ("Dyadic" announced that it repurchased and retired an aggregate of 2,136,752 shares of its common stock at $1.35 per share for an aggregate purchase price of $2,884,615 pursuant to a Securities Purchase Agreement entered into with Abengoa Bioenergy New Technologies, LLC ("ABNT" on January 12, 2016. The $1.35 per share price is equal to the average conversion price that Dyadic convertible debt holders received upon conversion of debt at December 31, 2015. DuPont Purchases Dyadic's Industrial Technology Business
Zacks Equity Research - Zacks Investment Research - Mon Jan 04, 8:40AM CST
DuPont (DD) declared that Dyadic International completed the sale of all of the assets of its Industrial Technology business to DuPont's Industrial Biosciences business.
CE: 64.72 (unch), DD: 61.85 (-1.11), DOW: 48.12 (-0.64)
Dyadic International, Inc. Announces Closing of Sale of Industrial Technology Business to Dupont Industrial Biosciences
GlobeNewswire - Thu Dec 31, 9:16AM CST
Dyadic International, Inc. (OTCQX
YAI) ("Dyadic" announced the closing of the previously announced sale of substantially all of the assets of its Industrial Technology business to DuPont's (NYSED) Industrial Biosciences business for $75 million in cash (the "Transaction". As previously announced, following the closing, Dyadic intends to focus exclusively on its biopharmaceutical business. DD: 61.85 (-1.11)
Dyadic International, Inc. Shareholders Approve Sale of Industrial Technology Business to DuPont Industrial Biosciences
GlobeNewswire - Fri Dec 11, 12:25PM CST
Dyadic International, Inc. (OTCQX
YAI) ("Dyadic" announced that at the special meeting of Dyadic shareholders held today, Dyadic's shareholders voted to approve the sale of substantially all of the enzyme and technology assets, including the C1 platform of Dyadic, Dyadic International (USA), Inc. ("Dyadic USA" and Dyadic Nederland B.V. to Danisco US Inc., a wholly-owned subsidiary of E. I. du Pont de Nemours and Company, ("Danisco" and its affiliate (the "Transaction" pursuant to the asset purchase and sale agreement, dated as of November 9, 2015, by and among Danisco, Dyadic USA and Dyadic (the "Transaction Agreement". Dyadic International Reports Third Quarter 2015 Financial Results
GlobeNewswire - Thu Nov 12, 3:30PM CST
Dyadic to Host Investor Conference Call Thursday, November 12, 2015 at 5:00PM EST
DuPont Industrial Biosciences to Acquire Biotechnology Assets from Dyadic
PRWeb - Tue Nov 10, 7:09AM CST
DuPont Industrial Biosciences (DuPont) has signed an agreement to purchase enzyme and technology assets from Dyadic International, Inc., including Dyadic's C1 platform, a fungal expression technology for producing enzymes. The transaction will further extend the world-leading biotechnology capabilities of DuPont's Industrial Biosciences business.
DD: 61.85 (-1.11)
